What are the recent trends in market size and growth for the veterinary oncology market?
The veterinary oncology market size has grown rapidly in recent years. It will grow from $0.4 billion in 2024 to $0.45 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing pet ownership, humanization of pets, knowledge transfer from human oncology, increasing awareness of pet health, and pharmaceutical developments.
The veterinary oncology market size is expected to see rapid growth in the next few years. It will grow to $0.69 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to personalized medicine for animals, rising prevalence of cancer in animals, growing geriatric pet population, expanded access to specialized care, regulatory support and approvals. Major trends in the forecast period include advanced diagnostic technologies, personalized treatment approaches, immunotherapy advancements, targeted therapies, telemedicine in oncology consultations.
Get Your Free Sample of The Global Veterinary Oncology Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp
How have varous drivers impacted the growth of the veterinary oncology market?
The growing prevalence of cancer in pets is expected to propel the veterinary oncology market going forward. Cancer is a disorder in which a few of the body’s cells grow out of control and spread to other body sections. Cancer in pets refers to the physical manifestations of a tumor, such as swelling. Veterinary oncology is focused on cancer diagnosis and therapy in animals by reducing metastasis and disease spread. As a result, an increase in pet cancer will boost the need for veterinary oncology. For instance, according to the The Cancer Letter, a US-based publication that covers cancer research stated that in 2024, an estimated 6 million pet dogs will be diagnosed with cancer in the United States. Furthermore, according to the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, November 2023, it’s estimated that 1 in 4 dogs and 1 in 5 cats will be diagnosed with cancer in their lifetime. Therefore, the growing prevalence of cancer in pets is driving the veterinary oncology market.
What are the primary segments of the veterinary oncology market?
The veterinary oncology market covered in this report is segmented –
1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies
2) By Animal Type: Equine, Canine, Feline, Other Animal Types
3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types
Subsegments:
1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation
2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques
3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents
4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report
Which firms are leading the veterinary oncology market?
Major companies operating in the veterinary oncology market include PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc.
Which transformative trends will shape the veterinary oncology market landscape?
Major companies operating in the veterinary oncology market are focused on developing neoantigens, which are unique tumor-specific antigens that arise from mutations in cancer cells. Neoantigens are unique protein fragments that arise from tumor-specific mutations in cancer cells. Unlike normal antigens found in healthy tissues, neoantigens are produced as a result of genetic changes (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company launched cancer vaccine trial for dogs. Neoantigens are being explored in the development of cancer vaccines and other immunotherapies, with the goal of enhancing the immune response specifically against cancer cells while sparing normal cells.
What are the major regional insights for the veterinary oncology market, and which region holds the top position?
Asia-Pacific was the largest region in the veterinary oncology market in 2024. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Veterinary Oncology Market Report 2025 Offer?
The veterinary oncology market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Veterinary oncology refers to the diagnosis and treatment of cancer by specially trained experts to integrate cancer treatment with underlying conditions while sustaining a quality of life in animals. It deals with cancer medicine and treatment services in animals.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
